|
13
|
52
|
2p93L |
Factor xa in complex with the inhibitor 5-chloro-n-(2-(4-(2-oxopyridin-1(2h)-yl)benzamido)ethyl)thiophene-2-carboxamide |
|
13
|
52
|
2p16L |
Factor xa in complex with the inhibitor apixaban (bms-562247) aka 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3, 4-c]pyridine-3-carboxamide |
|
12
|
74
|
2p3fN |
Crystal structure of the factor xa/nap5 complex |
|
34
|
217
|
2p28B |
Structure of the phe2 and phe3 fragments of the integrin beta2 subunit |
|
13
|
99
|
2mgpA |
Structure of plasmodium yoelii merozoite surface protein 1 - c-terminal domain |
|
9
|
103
|
2mhpA |
Solution structure of the major factor viii binding region on von willebrand factor |
|
10
|
136
|
2m74A |
1h, 13c and 15n assignments of the four n-terminal domains of human fibrillin-1 |
|
15
|
99
|
2mgrA |
Structure of plasmodium yoelii merozoite surface protein 1 - c-terminal domain, e28k mutant |
|
4
|
90
|
2nprA |
Structural studies on plasmodium vivax merozoite surface protein-1 |
|
5
|
41
|
2kniA |
High-resolution solution structure of the asic1a blocker pctx1 |
|
8
|
53
|
2kv4A |
Egf |
|
6
|
55
|
2k2sB |
Structure of the mic1-gld/mic6-egf complex from toxoplasma gondii |
|
4
|
44
|
2kb9A |
Human jagged-1, exon 6 |
|
7
|
57
|
2k2tA |
Epidermal growth factor-like domain 2 from toxoplasma gondii microneme protein 6 |
|
6
|
71
|
2kl7A |
Solution nmr structure of the egf-like 1 domain of human fibulin-4. northeast structural genomics target hr6275 |
|
52
|
207
|
2jjlA |
Structure of avian reovirus sigmac117-326, p321 crystal form |
|
12
|
54
|
2jkhL |
Factor xa - cation inhibitor complex |
|
11
|
51
|
2j38B |
Crystal structure of a human factor xa inhibitor complex |
|
12
|
52
|
2j95B |
Crystal structure of a human factor xa inhibitor complex |
|
12
|
52
|
2j4iB |
Crystal structure of a human factor xa inhibitor complex |
|
13
|
52
|
2j94B |
Crystal structure of a human factor xa inhibitor complex |
|
12
|
52
|
2j34B |
Crystal structure of a human factor xa inhibitor complex |
|
30
|
123
|
2i9aA |
Crystal structure of the free aminoterminal fragment of urokinase type plasminogen activator (atf) |
|
12
|
52
|
2j2uB |
Crystal structure of a human factor xa inhibitor complex |
|
24
|
122
|
2i9bA |
Crystal structure of atf-urokinase receptor complex |
|
9
|
48
|
2h9eL |
Crystal structure of fxa/selectide/napc2 ternary complex |
|
145
|
425
|
2hoxA |
Alliinase from allium sativum (garlic) |
|
145
|
425
|
2horA |
Crystal structure of alliinase from garlic- apo form |
|
9
|
78
|
2h9eC |
Crystal structure of fxa/selectide/napc2 ternary complex |
|
11
|
52
|
2gd4A |
Crystal structure of the antithrombin-s195a factor xa-pentasaccharide complex |
|
12
|
52
|
2g00L |
Factor xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridin-1-yl)benzamide |
|
13
|
52
|
2fzzL |
Factor xa in complex with the inhibitor 1-(3-amino-1,2-benzisoxazol-5-yl)-6-(2'-(((3r)-3-hydroxy-1-pyrrolidinyl)methyl)-4-biphenylyl)-3-(trifluoromethyl)-1,4,5,6-tetrahydro-7h-pyrazolo[3,4-c]pyridin-7-one |
|
17
|
96
|
2flrL |
Novel 5-azaindole factor viia inhibitors |
|
21
|
96
|
2flbL |
Discovery of a novel hydroxy pyrazole based factor ixa inhibitor |
|
2
|
48
|
2flgA |
Solution structure of an egf-like domain from the plasmodium falciparum merozoite surface protein 1 |
|
25
|
122
|
2fd6A |
Structure of human urokinase plasminogen activator in complex with urokinase receptor and an anti-upar antibody at 1.9 a |
|
18
|
94
|
2f9bL |
Discovery of novel heterocyclic factor viia inhibitors |
|
12
|
54
|
2ei8B |
Factor xa in complex with the inhibitor (1s,2r,4s)-n1-[(5-chloroindol-2-yl)carbonyl]-4-(n,n-dimethylcarbamoyl)-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
12
|
54
|
2ei6B |
Factor xa in complex with the inhibitor (-)-cis-n1-[(5-chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
11
|
54
|
2ei7B |
Factor xa in complex with the inhibitor trans-n1-[(5-chloroindol-2-yl)carbonyl]-n2-[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]-1,2-cyclohexanediamine |
|
63
|
307
|
2dduA |
Crystal structure of the third repeat domain of reelin |
|
12
|
52
|
2cjiB |
Crystal structure of a human factor xa inhibitor complex |
|
12
|
54
|
2d1jB |
Factor xa in complex with the inhibitor 2-[[4-[(5-chloroindol-2-yl)sulfonyl]piperazin-1-yl] carbonyl]thieno[3,2-b]pyridine n-oxide |
|
11
|
53
|
2bz6L |
Orally available factor7a inhibitor |
|
10
|
52
|
2bq6A |
Crystal structure of factor xa in complex with 21 |
|
29
|
141
|
2boxA |
Egf domains 1,2,5 of human emr2, a 7-tm immune system molecule, in complex with strontium. |
|
27
|
141
|
2bouA |
Egf domains 1,2,5 of human emr2, a 7-tm immune system molecule, in complex with barium. |
|
35
|
176
|
2bsfA |
Structure of the c-terminal receptor-binding domain of avian reovirus fibre sigmac, zn crystal form. |
|
10
|
53
|
2bmgA |
Crystal structure of factor xa in complex with 50 |
|
35
|
170
|
2bt7A |
Structure of the c-terminal receptor-binding domain of avian reovirus fibre sigmac, cd crystal form |
